They hope the website will be an unbiased source for genetic risk information, testing, and financial support services and spur cascade testing in families.
Physician Bias May Contribute to Lower Genetic Testing Rates Among Black Women, Study Suggests
Researchers explored how oncologists' beliefs about the barriers Black breast cancer patients face in accessing genetic counseling and testing might influence testing referrals.
BMS' Opdivo-Chemo Regimen Garners EC Approval for PD-L1-Positive Gastroesophageal Cancer
The European approval is more restrictive than the approval in the US, though regulators reviewed data from the same trial.
European Commission Approves Merck's Keytruda-Chemo Combination for Advanced TNBC Patients
The approval makes Merck's PD-1 inhibitor available to European TNBC patients whose tumors express PD-L1 with a combined positive score of at least 10.